Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update

被引:76
|
作者
Lin, Yiping [1 ]
Li, Yuke [1 ]
Zeng, Yuanlian [1 ]
Tian, Bin [1 ]
Qu, Xiaolan [1 ]
Yuan, Qianghua [2 ]
Song, Ying [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Affiliated Hosp, Chengdu, Peoples R China
关键词
magnolol; pharmacology; toxicity; bioavailability; formulation; NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; INDUCED INFLAMMATORY RESPONSE; NATURAL-PRODUCTS MAGNOLOL; STIMULATE GLUCOSE-UPTAKE; IN-VITRO; CANCER-CELLS; SIGNALING PATHWAY; OXIDATIVE STRESS; PPAR-GAMMA;
D O I
10.3389/fphar.2021.632767
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine
    Wei, Shichao
    Xiao, Junshen
    Ju, Feng
    Liu, Jin
    Hu, Zhaoyang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [2] Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity
    Xu, Sijin
    Chen, Shuaipeng
    Xia, Wenxin
    Sui, Hong
    Fu, Xueyan
    MOLECULES, 2022, 27 (09):
  • [3] Pharmacokinetics, Bioavailability, and Tissue Distribution of Magnolol Following Single and Repeated Dosing of Magnolol to Rats
    Lin, Shiuan-Pey
    Tsai, Shang-Yuan
    Chao, Pei-Dawn Lee
    Chen, Ying-Chen
    Hou, Yu-Chi
    PLANTA MEDICA, 2011, 77 (16) : 1800 - 1805
  • [4] Improved oral bioavailability of magnolol by using a binary mixed micelle system
    Ding, Pinggang
    Shen, Hongxue
    Wang, Jianan
    Ju, Jianming
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 668 - 674
  • [5] Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
    Dong, Xiaoxv
    Fu, Jing
    Yin, Xingbin
    Cao, Sali
    Li, Xuechun
    Lin, Longfei
    Huyiligeqi
    Ni, Jian
    PHYTOTHERAPY RESEARCH, 2016, 30 (08) : 1207 - 1218
  • [6] Sophoridine: A review of its pharmacology, pharmacokinetics and toxicity
    Wang, Qi
    Li, Ying
    Li, Kun-Wei
    Zhou, Chang-Zheng
    PHYTOMEDICINE, 2022, 95
  • [7] Imperatorin: A review of its pharmacology, toxicity and pharmacokinetics
    Deng, Mao
    Xie, Long
    Zhong, Li
    Liao, Yanmei
    Liu, Luona
    Li, Xiaofang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 879
  • [8] Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61
    Shen, Hongxue
    Liu, Sheng
    Ding, Pinggang
    Wang, Lulu
    Ju, Jianming
    Liang, Guohui
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 70 (04) : 498 - 506
  • [9] Nutmegs and wild nutmegs: An update on ethnomedicines, phytochemicals, pharmacology, and toxicity of the Myristicaceae species
    Barman, Rubi
    Bora, Pranjit Kumar
    Saikia, Jadumoni
    Kemprai, Phirose
    Saikia, Siddhartha Proteem
    Haldar, Saikat
    Banik, Dipanwita
    PHYTOTHERAPY RESEARCH, 2021, 35 (09) : 4632 - 4659
  • [10] Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches
    Sun, Qiang
    Xie, Long
    Song, Jiawen
    Li, Xiaofang
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 262